Skip to content

Combined Functional Exercises with Mindfulness for improve physical and cognitive function in Older Adults with Slow Gait Speed and Cognitive Complaints

Optimizing the body-mind interaction through combining Functional Exercises and Mindfulness: effects on physical and cognitive function of Seniors with Motoric Cognitive Risk Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5z5h789
Enrollment
Unknown
Registered
2022-02-22
Start date
2022-03-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive dysfunction

Interventions

Intervention group: Functional Exercises + Mindfulness (Ex-Mind) 54 participants with MOTORIC Cognitive Risk Syndrome will be allocated to the Ex-Mind group and they will undergo a protocol of 24-wee

Sponsors

Universidade de Pernambuco - UPE (Campus Petrolina)
Lead Sponsor
Universidade de Pernambuco - UPE (Campus Petrolina)
Collaborator

Eligibility

Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: We will recruit older adults, 65 years and older, with MOTORIC Cognitive Risk Syndrome

Exclusion criteria

Exclusion criteria: We will exclude participants who have the following criteria. not being able to speak and understand the Portuguese; not being able to walk at least 10 meters without mobility aids (eg, cane); participate in structured physical exercise programs for at least 3 months; have exacerbated walking impairment due to musculoskeletal disorders or neurological motor deficit (eg, severe osteoarthritis, lower limb amputation, Parkinson's disease, stroke with motor sequelae); use antipsychotic-type drugs, have a diagnosis of major depression or any-type dementia; have unstable cardiovascular or metabolic diseases (eg, angina pectoris, decompensated diabetes) or chronic complications (eg, retinopathy, neuropathy) that precludes structure exercise engagement; not having adequate visual and auditory capacity to perform the cognitive assessments

Design outcomes

Primary

MeasureTime frame
To assess the changes in physical function through the Short Physical Performance Battery scores (0-12) from baseline to 24-weeks follow-up;To assess the changes in global cognitive function through the Montreal Cognitive Assessment (0-30) scores from baseline to 24-weeks follow-up

Secondary

MeasureTime frame
To assess the changes in executive functioning through measures of Trail Making Test A (in seconds), Digit Span of WAIS-III (score) and verbal fluency (animal naming) from baseline to 24-weeks follow-up;To assess the changes in mobility and dynamic balance through measures of gait-related variables and scales such 6-meters walking speed test (in m/s), Timed Up and Go (in seconds) and Activities-specific Balance Confidence scale (scores) from baseline to 24-weeks follow-up;To assess the changes in muscle strength and upper limb power through measures of leg extension peak of torque (in Nm) and seated Medicine Ball throw (distance in meters) from baseline to 24-weeks follow-up;To assess the changes in muscular thickness of quadriceps (body composition) through Ultrasonography (in m3) from baseline to 24-weeks follow-up;To assess the changes in blood pressure (in mmHg), heart-rate variability parameters and vascular health parameters (using different units) through a blood pressure monitor, cardiac monitor and ultrasonography, respectively, from baseline to 24-weeks follow-up;To assess the changes in time spent in physical activities and sedentary behaviour (as measures of healthy behaviours) in minutes/week using smartwatch based-technologies or accelerometers from baseline to 24-weeks follow-up;To assess the changes in health-related quality of life through questionnaire (in scores) from baseline to 24-weeks follow-up

Countries

Brazil

Contacts

Public ContactRodrigo de Araújo

Universidade de Pernambuco - UPE (Campus Petrolina)

rodrigo.cappato@upe.br+55-87-3866-6496

Outcome results

None listed

Source: REBEC (via WHO ICTRP)